REVVITY DANMARK A/S: Financial statements 2012
CVR: 15288981
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
REVVITY DANMARK A/S (CVR 15288981) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 27,168,328 and a net result of DKK 5,073,968. The profit margin was 18.7%. Equity in the 2012 report amounted to DKK 11,982,971. The solvency ratio was 53.3%.
- Revenue
- DKK 27,168,328
- Gross Profit
- DKK 27,168,328
- Profit/Loss
- DKK 5,073,968
- Equity
- DKK 11,982,971
- Total Assets
- DKK 22,462,197
Official annual report
Keep an eye on REVVITY DANMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 31, 2012, Forvis Mazars Statsautoriseret Revisionspartnerselskab has been appointed auditor of REVVITY DANMARK A/S.
As of December 31, 2012, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of REVVITY DANMARK A/S.
About REVVITY DANMARK A/S
REVVITY DANMARK A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1991. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named PERKINELMER DANMARK A/S and WALLAC DANMARK A/S. The management consists of Christopher James Hughes. The board consists of Malak Benyakhlef (chair), Christopher James Hughes and John Healy. The company is owned by Wallac OY. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 14,917,729 and a net result of DKK 3,191,625 compared with DKK 4,245,874 the year before. Equity in the 2025 report amounted to DKK 39,265,821.